{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:37:09Z","timestamp":1775619429453,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T00:00:00Z","timestamp":1277769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11934-010-0130-8","type":"journal-article","created":{"date-parts":[[2010,6,28]],"date-time":"2010-06-28T06:27:45Z","timestamp":1277706465000},"page":"343-347","source":"Crossref","is-referenced-by-count":33,"title":["Urodynamics in the Evaluation of Overactive Bladder"],"prefix":"10.1007","volume":"11","author":[{"given":"Eric S.","family":"Rovner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin M.","family":"Goudelocke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,29]]},"reference":[{"key":"130_CR1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1067\/mob.2002.125704","volume":"187","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, et al.: The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002, 187:116\u2013126.","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Suppl 2","key":"130_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.urology.2003.09.050","volume":"62","author":"P Abrams","year":"2003","unstructured":"Abrams P: Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology 2003, 62(5 Suppl 2):28\u201337.","journal-title":"Urology"},{"key":"130_CR3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1464-410X.2009.09037.x","volume":"105","author":"VW Nitti","year":"2010","unstructured":"\u2022\u2022 Nitti VW, Rovner ES, Bavendam T: Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int 2010, 105:1268\u20131275. In this report from a randomized placebo-controlled trial of fesoterodine, response of overactive bladder symptoms to antimuscarinic treatment was not dependent on finding of detrusor overactivity on pretreatment urodynamics.","journal-title":"BJU Int"},{"key":"130_CR4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1464-410X.2009.08361.x","volume":"103","author":"JG Malone-Lee","year":"2009","unstructured":"\u2022\u2022 Malone-Lee JG, Al-Buheissi S: Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study. BJU Int 2009, 103:931\u2013937. In this trial of tolterodine-ER, patients were stratified into groups of patients with and without pretreatment detrusor overactivity. Presence of detrusor overactivity could not be used to predict response to treatment or placebo, suggesting that urodynamic assessment of detrusor overactivity may not be required before treatment of overactive bladder with antimuscarinic therapy.","journal-title":"BJU Int"},{"issue":"4 Suppl","key":"130_CR5","first-page":"e591","volume":"183","author":"R Eric","year":"2010","unstructured":"Eric R: Urodynamic results and clinical outcomes with intravesical botulinum toxin a (onabotuliumtoxina) in a randomized, placebo-controlled, dose-finding study in idiopathic overactive bladder. J Urol 2010, 183(4 Suppl):e591\u2013e592.","journal-title":"J Urol"},{"key":"130_CR6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00192-007-0351-7","volume":"18","author":"MM South","year":"2007","unstructured":"\u2022 South MM, Romero AA, Jamison MG, et al.: Detrusor overactivity does not predict outcome of sacral neuromodulation test stimulation. Int Urogynecol J Pelvic Floor Dysfunct 2007, 18:1395\u20131398. This retrospective review found that patients characterized as responders to test neurostimulation for overactive bladder were not more likely to have detrusor overactivity on pretreatment urodynamics than those who failed to respond to a test stimulation, suggesting that detrusor overactivity is not a requirement for test neurostimulation.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"130_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/nau.10099","volume":"22","author":"GA Digesu","year":"2003","unstructured":"Digesu GA, Khullar V, Cardozo L, Salvatore S: Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn 2003, 22:105\u2013108. (Published erratum appears in Neurourol Urodyn 2003, 22:356.)","journal-title":"Neurourol Urodyn"},{"key":"130_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-5347(05)00067-4","volume":"175","author":"H Hashim","year":"2006","unstructured":"Hashim H, Abrams P: Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 2006, 175:191\u2013194.","journal-title":"J Urol"},{"key":"130_CR9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/nau.20680","volume":"28","author":"L Lowenstein","year":"2009","unstructured":"Lowenstein L, Pham T, Abbasy S, et al.: Observations relating to urinary sensation during detrusor overactivity. Neurourol Urodyn 2009, 28:497\u2013500.","journal-title":"Neurourol Urodyn"},{"key":"130_CR10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/nau.20679","volume":"28","author":"A Renganathan","year":"2009","unstructured":"Renganathan A, Cartwright R, Cardozo L, et al.: Quality control in urodynamics: Analysis of an international multi-center study. Neurourol Urodyn 2009, 28:380\u2013384.","journal-title":"Neurourol Urodyn"},{"key":"130_CR11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1471-0528.1996.tb09769.x","volume":"103","author":"K Heslington","year":"1996","unstructured":"Heslington K, Hilton P: Ambulatory monitoring and conventional cystometry in asymptomatic female volunteers. Br J Obstet Gynaecol 1996, 103:434\u2013441.","journal-title":"Br J Obstet Gynaecol"},{"key":"130_CR12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.urology.2009.10.045","volume":"75","author":"SR Lee","year":"2010","unstructured":"Lee SR, Kim HJ, Kim A, Kim JH: Overactive bladder is not only overactive but also hypersensitive. Urology 2010, 75:1053\u20131059.","journal-title":"Urology"},{"key":"130_CR13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/nau.20727","volume":"29","author":"CH Ho","year":"2010","unstructured":"Ho CH, Tai HC, Yu HJ: Urodynamic findings in female diabetic patients with and without overactive bladder symptoms. Neurourol Urodyn 2010, 29:424\u2013427.","journal-title":"Neurourol Urodyn"},{"key":"130_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00192-009-1030-7","volume":"21","author":"ML Guralnick","year":"2010","unstructured":"Guralnick ML, Grimsby G, Liss M, et al.: Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity. Int Urogynecol J Pelvic Floor Dysfunct 2010, 21:325\u2013329.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"6A Suppl","key":"130_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0090-4295(97)00591-8","volume":"50","author":"AF Brading","year":"1997","unstructured":"Brading AF: A myogenic basis for the overactive bladder. Urology 1997, 50(6A Suppl):57\u201367.","journal-title":"Urology"},{"key":"130_CR16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0022-5347(05)00315-0","volume":"175","author":"C Maake","year":"2006","unstructured":"Maake C, Landman M, Wang X, et al.: Expression of smoothelin in the normal and the overactive human bladder. J Urol 2006, 175:1152\u20131157.","journal-title":"J Urol"},{"key":"130_CR17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2005.04.019","volume":"48","author":"DE Rapp","year":"2005","unstructured":"Rapp DE, Lyon MB, Bales GT, Cook SP: A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction. Eur Urol 2005, 48:303\u2013308.","journal-title":"Eur Urol"},{"issue":"Suppl 2","key":"130_CR18","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1038\/sj.bjp.0706637","volume":"147","author":"AP Ford","year":"2006","unstructured":"Ford AP, Gever JR, Nunn PA, et al.: Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol 2006, 147(Suppl 2):S132\u2013S143.","journal-title":"Br J Pharmacol"},{"key":"130_CR19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/nau.20208","volume":"25","author":"K Laet De","year":"2006","unstructured":"De Laet K, De Wachter S, Wyndaele JJ: Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics. Neurourol Urodyn 2006, 25:156\u2013161.","journal-title":"Neurourol Urodyn"},{"key":"130_CR20","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.eururo.2007.02.057","volume":"52","author":"K Iijima","year":"2007","unstructured":"Iijima K, De Wachter S, Wyndaele JJ: Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve. Eur Urol 2007, 52:842\u2013847.","journal-title":"Eur Urol"},{"key":"130_CR21","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1464-410X.2007.06903.x","volume":"100","author":"S Boy","year":"2007","unstructured":"Boy S, Schurch B, Mehnert U, et al.: The effects of tolterodine on bladder-filling sensations and perception thresholds to intravesical electrical stimulation: method and initial results. BJU Int 2007, 100:574\u2013578.","journal-title":"BJU Int"},{"key":"130_CR22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1464-410X.2006.06258.x","volume":"98","author":"SM Finney","year":"2006","unstructured":"Finney SM, Andersson KE, Gillespie JI, Stewart LH: Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int 2006, 98:503\u2013507.","journal-title":"BJU Int"},{"key":"130_CR23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00192-010-1123-3","volume":"21","author":"DC Panayi","year":"2010","unstructured":"Panayi DC, Tekkis P, Fernando R, Khullar V: Is the beneficial effect of antimuscarinics related to motor or sensory changes in the bladder? Int Urogynecol J Pelvic Floor Dysfunct 2010, 21:841\u2013845.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"130_CR24","first-page":"85","volume":"60","author":"K Juszczak","year":"2009","unstructured":"Juszczak K, Ziomber A, Wyczolkowski M, Thor PJ: Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats. J Physiol Pharmacol 2009, 60:85\u201391.","journal-title":"J Physiol Pharmacol"},{"key":"130_CR25","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59745-368-4","volume-title":"Female urology: a practical clinical guide","author":"HB Goldman","year":"2007","unstructured":"Goldman HB, Vasavada SP: Female urology: a practical clinical guide. Totowa, NJ: Humana Press; 2007."},{"key":"130_CR26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.urology.2007.11.039","volume":"71","author":"A Sahai","year":"2008","unstructured":"Sahai A, Khan MS, Le Gall N, et al.: Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder. Urology 2008, 71:455\u2013459.","journal-title":"Urology"},{"key":"130_CR27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/nau.20611","volume":"28","author":"BL Cohen","year":"2009","unstructured":"Cohen BL, Barboglio P, Rodriguez D, Gousse AE: Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units. Neurourol Urodyn 2009, 28:205\u2013208.","journal-title":"Neurourol Urodyn"},{"key":"130_CR28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1464-410X.2007.07258.x","volume":"101","author":"PM Groenendijk","year":"2008","unstructured":"\u2022 Groenendijk PM, Lycklama a Nyeholt AA, Heesakkers JP, et al.: Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence. BJU Int 2008, 101:325\u2013329. This study of patients with neurostimulator placement for overactive bladder found that even those patients with pretreatment detrusor overactivity on urodynamics who had resolution of their detrusor overactivity 6 months later while the stimulator was on had no difference in rates of improvement in symptoms over those patients who had no resolution of detrusor overactivity.","journal-title":"BJU Int"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-010-0130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-010-0130-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-010-0130-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T07:27:36Z","timestamp":1635578856000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-010-0130-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,29]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1007\/s11934-010-0130-8","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,29]]}}}